Singular Genomics Systems, Inc. (Nasdaq: OMIC) (“Singular Genomics” or the “Company”), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, L.P. will acquire Singular Genomics in an all-cash transaction for $20.00 per share. The $20.00 per share represents 254% premium to the last closing share price for Singular’s common stock prior to the September 12, 2024 public disclosure of Deerfield’s initial acquisition proposal.
Read the full article: Singular Genomics Enters into Agreement to Be Acquired by Deerfield for $20.00 in Cash per Share //
Source: https://www.globenewswire.com/news-release/2024/12/23/3001234/0/en/Singular-Genomics-Enters-into-Agreement-to-be-Acquired-by-Deerfield-for-20-00-in-Cash-per-Share.html